Celsius Holdings Inc. (NASDAQ:CELH – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $47.24.
A number of analysts have recently weighed in on the stock. TD Cowen raised shares of Celsius from a “hold” rating to a “buy” rating and upped their target price for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. LADENBURG THALM/SH SH reduced their target price on shares of Celsius from $62.00 to $58.00 and set a “neutral” rating on the stock in a research report on Thursday, March 27th. JPMorgan Chase & Co. upped their target price on shares of Celsius from $39.00 to $44.00 and gave the stock an “overweight” rating in a research report on Friday, May 2nd. UBS Group upped their target price on shares of Celsius from $43.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, April 17th. Finally, B. Riley reaffirmed a “buy” rating and issued a $49.00 target price (up from $44.00) on shares of Celsius in a research report on Friday, February 21st.
Read Our Latest Stock Report on CELH
Insider Activity
Institutional Trading of Celsius
A number of institutional investors have recently made changes to their positions in the stock. Alliancebernstein L.P. boosted its holdings in shares of Celsius by 26.3% during the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after acquiring an additional 3,753,055 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Celsius by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company’s stock worth $416,517,000 after purchasing an additional 345,837 shares during the period. Alyeska Investment Group L.P. lifted its stake in shares of Celsius by 60.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock worth $181,164,000 after purchasing an additional 2,591,345 shares during the period. FMR LLC lifted its stake in shares of Celsius by 64.2% in the 4th quarter. FMR LLC now owns 4,055,148 shares of the company’s stock worth $106,813,000 after purchasing an additional 1,585,839 shares during the period. Finally, Champlain Investment Partners LLC bought a new position in shares of Celsius in the 4th quarter worth approximately $85,068,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.
Celsius Trading Down 1.6%
Shares of NASDAQ CELH opened at $43.37 on Wednesday. Celsius has a 12 month low of $21.10 and a 12 month high of $62.68. The firm has a market capitalization of $11.18 billion, a PE ratio of 135.54, a price-to-earnings-growth ratio of 1.58 and a beta of 1.43. The firm has a fifty day simple moving average of $38.07 and a two-hundred day simple moving average of $31.73.
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. Celsius had a return on equity of 42.12% and a net margin of 8.40%. The firm’s revenue for the quarter was down 7.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.27 earnings per share. On average, sell-side analysts predict that Celsius will post 0.89 earnings per share for the current year.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- The Most Important Warren Buffett Stock for Investors: His Own
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Why Invest in 5G? How to Invest in 5G Stocks
- Overheated Market? Analysts Watch These Red Flags
- Stock Sentiment Analysis: How it Works
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.